Rechallenge with cisplatin in a patient with pancreatic cancer who developed a hypersensitivity reaction to oxaliplatin. Is skin test useful in this setting?

Journal of the Pancreas

Volumn 9, Issue 2, 2008, Pages 197-202

  Elligers, Kyle T ^a   Davies, Marianne ^a   Sanchis, Desiree ^a   Ferencz, Thomas ^a   Saif, Muhammad Wasif ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anaphylaxis; Bronchial spasm; Cisplatin; Exanthema; Hypersensitivity; Oxaliplatin; Pancreatic neoplasms; Skin tests

Indexed keywords

ADRENALIN; CISPLATIN; DEXAMETHASONE; DIPHENHYDRAMINE; FAMOTIDINE; GEMCITABINE; GLUCONATE CALCIUM; LORAZEPAM; MAGNESIUM SULFATE; MANNITOL; ONDANSETRON; OXALIPLATIN; PETHIDINE; POTASSIUM CHLORIDE;

ADULT; ADVANCED CANCER; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CHEMOTHERAPY INDUCED EMESIS; CHEST TIGHTNESS; COLD SENSITIVITY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPNEA; ENDOSCOPIC ECHOGRAPHY; FACE ERYTHEMA; FATIGUE; HOT FLUSH; HUMAN; HUMAN TISSUE; HYPERSENSITIVITY REACTION; IMMUNOHISTOCHEMISTRY; INTRACUTANEOUS TEST; LIP DISEASE; LIVER BIOPSY; MALE; METASTASIS; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUROPATHY; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS ADENOCARCINOMA; PROVOCATION TEST; RIGOR; SIDE EFFECT; VOMITING;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; CISPLATIN; DRUG HYPERSENSITIVITY; HUMANS; INTRADERMAL TESTS; MALE; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; PANCREATIC NEOPLASMS;

EID: 42949120522     PISSN: None     EISSN: 15908577     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Burris HA 3rd, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, et al. Improvements in survival and clinical benefit with genicitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 1997; 15:2403-13.
2. Heinemann V, Labianca R, Hinke A, Louvet C. Increased survival using platinum combined with gemcitabine as compared to single-agent gemcitabine in advanced pancreatic cancer: pooled analysis of two randomized trials, the GERCOR/GISCAD intergroup study, and a German multicenter study. Ann Oncol 2007; 18:1652-9.
3. Saif MW, Kim R. Role of platinum agents in the management of advanced pancreatic cancer. Expert Opin Pharmacother 2007; 8:2719-27.
4. Saif MW. Hypersensitivity reactions associated with oxaliplatin. Expert Opin Drug Saf 2006; 5:687-94.
5. National Cancer Institute. Common Terminology Criteria for Adverse Events v3.0. (CTCAE). Publish date August 9, 2006.
6. Markman M, Zanotti K, Peterson G, Kulp B, Webster K, Belinson J. Expanded experience with an intradermal skin test to predict for the presence or absence of carboplatin hypersensitivity. J Clin Oncol 2003; 21:4611-4.
7. Louvet C, Labianca R, Hammel P, Lledo G, Zampino MG, André T, et al. Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial. J Clin Oncol 2005; 23:3509-16.
8. Wrzesinski SH, McGurk ML, Donovan CT, Ferencz TM, Saif MW. Successful desensitization to oxaliplatin with incorporation of calcium gluconate and magnesium sulfate. Anticancer Drugs 20071; 18:721-4.
9. Goldberg A, Confino-Cohen R, Fishman A, Beyth Y, Altaras M. A modified, prolonged desensitization protocol in carboplatin allergy. J Allergy Clin Immunol 1996; 98:841-3.
10. Meyer L, Zuberbier T, Worm M, Oettle H, Riess H. Hypersensitivity reactions to oxaliplatin: cross-reactivity to carboplatin and the introduction of a desensitization schedule. J Clin Oncol 2002; 20:1146-7.
11. Heinemann V, Quietzkh D, Gieseler F, Gonnermann M, Schönekäs H, Rost A, et al. Randomized phase III trial of genicitabine plus cisplatin compared with gemcitabine alone in advanced pancreatic cancer. J Clin Oncol 2006; 24:3946-52.
12. Saif MW. Pancreatic cancer: is this bleak landscape finally changing? Highlights from the 43rd ASCO Annual Meeting. Chicago, IL, USA. June 1-5, 2007. JOP. J Pancreas (Online) 2007; 8:365-73.
13. Xie DR, Liang HL, Wang Y, Guo SS, Yang Q. Meta-analysis on inoperable pancreatic cancer: a comparison between gemcitabine-based combination therapy and gemcitabine alone. World J Gastroenterol 2006; 12:6973-81.
14. Shepherd GM. Hypersensitivity reactions to chemotherapeutic drugs. Clin Rev Allergy Immunol 2003; 24:253-62.
15. Brandi G, Pantaleo MA, Galli C, Falcone A, Antonuzzo A, Mordenti P, et al. Hypersensitivity reactions related to oxaliplatin (OHP). Br J Cancer 2003; 89:477-81.
16. Siu SW, Chan RT, Au GK. Hypersensitivity reactions to oxaliplatin: experience in a single institute. Ann Oncol 2006; 17:259-61.
17. Gowda A, Goel R, Berdzik J, Leichman CG, Javle M. Hypersensitivity Reactions to oxaliplatin: incidence and management. Oncology (Williston Park) 2004; 18: 1671-5.
18. Thomas RR, Quinn MG, Schuler B, Grem JL. Hypersensitivity and idiosyncratic reactions to oxaliplatin. Cancer 2003; 97:2301-7.
19. Koren C, Yerushalmi R, Katz A, Malik H, Sulkes A, Fenig E. Hypersensitivity reaction to cisplatin during chemoradiation therapy for gynecologic malignancy. Am J Clin Oncol 2002; 25:625-6.
20. Shlebak AA, Clark PI, Green JA. Hypersensitivity and cross-reactivity to cisplatin and analogues. Cancer Chemother Pharmacol 1995; 35:349-51.
21. Markman M. Toxicities of the platinum antineoplastic agents. Expert Opin Drug Saf 2003; 2:597-607.
22. Stahl M, Köster W, Wilke H. Reaction after oxaliplatin-prevention with corticosteroids? Ann Oncol 2001; 12:874.
23. Zanotti KM, Markman M. Prevention and management of antineoplastic-induced hypersensitivity reactions. Drug Saf 2001; 24:767-79.
24. Hochster HS, Grothey A, Childs BH. Use of calcium and magnesium salts to reduce oxaliplatin-related neurotoxicity. J Clin Oncol 2007; 25:4028-9.
25. Porzio G, Marchetti P, Paris I, Narducci F, Ricevuto E, Ficorella C. Hypersensitivity reaction to carboplatin: successful resolution by replacement with cisplatin. Eur J Gynaecol Oncol 2002; 23:335-6.
26. Gottlieb MJ, Nelson B, Perry W. Utility of skin test for allergy to carboplatin or cisplatin. J Allergy Clin Immunol 1998; 101:S139.
27. Leguy-Soguin V, Jolimoy G, Coudert B, Pernot C, Dalac S, Vabres P, Collet E. Diagnostic and predictive value of skin testing in platinum salt hypersensitivity. J Allergy Clin Immunol 2007; 119:726-30.